Literature DB >> 9629846

Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.

R G Will1, A Alperovitch, S Poser, M Pocchiari, A Hofman, E Mitrova, R de Silva, M D'Alessandro, N Delasnerie-Laupretre, I Zerr, C van Duijn.   

Abstract

After the occurrence of bovine spongiform encephalopathy (BSE), there has been concern that transmission of BSE to the human population might result in a change in the epidemiological characteristics of Creutzfeldt-Jakob disease (CJD). A collaborative study of CJD in the European Union was performed from 1993 to 1995, to compare data from national registries for CJD in France, Germany, Italy, The Netherlands, Slovakia, and the United Kingdom. Five hundred seventy-five patients with definite or probable CJD died in the study period with an overall annual mortality rate of 0.71 cases per million. The incidence rates for CJD were similar in all participating countries despite variations in postmortem rates, and age-specific incidence rates were also relatively consistent, with the exception of an increased incidence of CJD in patients younger than 39 years of age in the United Kingdom. In relation to etiological subtypes of CJD, 87% of cases were sporadic, 8% genetic, and 5% iatrogenic. Genetic forms of CJD comprised 80% of all cases in Slovakia, and iatrogenic forms of CJD occurred most frequently in France and the United Kingdom. The statistical data reported here do not provide evidence of a causal link between BSE and CJD in Europe as a whole. However, the study has established baseline epidemiological parameters for CJD in participating European countries, which may be important in the assessment of any future change in the characteristics of CJD as a result of the epidemic of BSE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629846     DOI: 10.1002/ana.410430611

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

1.  vCJD: the epidemic that never was. New variant Creutzfeldt-Jakob disease: the critique that never was.

Authors:  R G Will; R S G Knight; H J T Ward; J W Ironside
Journal:  BMJ       Date:  2002-07-13

2.  Incidence of Creutzfeldt-Jakob disease in Taiwan: a prospective 10-year surveillance.

Authors:  Chien-Jung Lu; Yu Sun; Shun-Sheng Chen
Journal:  Eur J Epidemiol       Date:  2010-03-24       Impact factor: 8.082

3.  First symptom and initial diagnosis in sporadic CJD patients in Germany.

Authors:  Anna Krasnianski; Judith Kaune; Klaus Jung; Hans A Kretzschmar; Inga Zerr
Journal:  J Neurol       Date:  2014-07-15       Impact factor: 4.849

Review 4.  Psychiatric and neuroimaging findings in Creutzfeldt-Jakob disease.

Authors:  Jennifer L Martindale; Michael D Geschwind; Bruce L Miller
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

5.  Requirements for mutant and wild-type prion protein misfolding in vitro.

Authors:  Geoffrey P Noble; Daniel J Walsh; Michael B Miller; Walker S Jackson; Surachai Supattapone
Journal:  Biochemistry       Date:  2015-01-22       Impact factor: 3.162

6.  Mortality from dementia in occupations at risk of exposure to bovine spongiform encephalopathy: analysis of death registrations.

Authors:  P Aylin; J Bunting; B De Stavola; M P Coleman
Journal:  BMJ       Date:  1999-04-17

7.  Ancestral origins of the prion protein gene D178N mutation in the Basque Country.

Authors:  Ana B Rodríguez-Martínez; Christian Barreau; Isabelle Coupry; Jordi Yagüe; Raquel Sánchez-Valle; Luis Galdós-Alcelay; Agustín Ibáñez; Antón Digón; Ignacio Fernández-Manchola; Cyril Goizet; Azucena Castro; Nerea Cuevas; Maite Alvarez-Alvarez; Marian M de Pancorbo; Benoît Arveiler; Juan J Zarranz
Journal:  Hum Genet       Date:  2005-04-02       Impact factor: 4.132

8.  Ethics in prion disease.

Authors:  Kendra Bechtel; Michael D Geschwind
Journal:  Prog Neurobiol       Date:  2013-07-29       Impact factor: 11.685

9.  Creutzfeldt-Jakob disease in Slovenia from 1985 to 2003.

Authors:  Mara Popović; Damjan Glavac; Sava Smerkolj; Viktor Svigelj; Gregor Kalan; Vesna Galvani; Maja Cernilec; Maja Bresjanac
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

10.  Source of variant Creutzfeldt-Jakob disease outside United Kingdom.

Authors:  Pascual Sanchez-Juan; Simon N Cousens; Robert G Will; Cornelia M van Duijn
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.